Search in:

Core Evidence Volume 11, 2016 - Issue

Journal homepage

Open access

120

Views

CrossRef citations to date

Altmetric

Review

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy

Fernanda S Tonin1 Pharmaceutical Sciences Postgraduate Program

Astrid Wiens2 Department of Pharmacy, Federal University of Parana, Curitiba, Brazil

Fernando Fernandez-Llimos3 Department of Social Pharmacy, Faculty of Pharmacy, Research Institute for Medicines (iMed.ULisboa), Universidade de Lisboa, Lisbon, Portugal

Roberto Pontarolo2 Department of Pharmacy, Federal University of Parana, Curitiba, BrazilCorrespondence[email protected]

Pages 49-61 | Published online: 14 Dec 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (17)

Mehmet Hanifi TANYERİ, Mehmet Emin BÜYÜKOKUROĞLU, Pelin TANYERİ, Rümeysa KELEŞ, Şeyma Nur BAŞARIR BOZKURT, Oguz MUTLU, Firuzan AKAR, Bekir Faruk ERDEN & Güner ULAK. (2022) Chronic Effects of Loxapine, Iloperidone, Paliperidone on Mice Isolated Vas Deferens ContractilityLoksapin, İloperidon, Paliperidon'un İzole Farelerde Vas Deferens Kasılması Üzerine Kronik Etkileri. Online Türk Sağlık Bilimleri Dergisi 7:1, pages 40-46.
Crossref

Rupali S. Bhadale & Vaishali Y. Londhe. (2022) Inclusion complexed iloperidone loaded dissolving microneedles: Characterization, in-vitro study, and dermatopharmacokinetics. Journal of Drug Delivery Science and Technology 68, pages 103063.
Crossref

Kyriaki Savva, Margarita Zachariou, Marilena M. Bourdakou, Nikolas Dietis & George M. Spyrou. (2022) Network-based stage-specific drug repurposing for Alzheimer’s disease. Computational and Structural Biotechnology Journal 20, pages 1427-1438.
Crossref

Ashwin Kumar N, Gowri Annasamy, Pavani Rekulapally, Suresh S N & Saravanan Krishnan. 2022. Applications of Nanotechnology in Drug Discovery and Delivery. Applications of Nanotechnology in Drug Discovery and Delivery 255 289 .

Hong Joon Lee, Bok Hee Choi, Jin-Sung Choi & Sang June Hahn. (2021) Effects of iloperidone on hERG 1A/3.1 heterotetrameric channels. NeuroReport 32:16, pages 1299-1306.
Crossref

Przemysław J. Danek, Wojciech Kuban & Władysława A. Daniel. (2021) The Effect of Chronic Iloperidone Treatment on Cytochrome P450 Expression and Activity in the Rat Liver: Involvement of Neuroendocrine Mechanisms. International Journal of Molecular Sciences 22:16, pages 8447.
Crossref

Alexandre Vallée, Jean-Noël Vallée & Yves Lecarpentier. (2021) Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma. Biomedicines 9:5, pages 473.
Crossref

Shrikant V. Joshi, Ekta P. Patel, Bhavin A. Vyas, Sandesh R. Lodha & Gajanan G. Kalyankar. (2020) Repurposing of Iloperidone: Antihypertensive and ocular hypotensive activity in animals. European Journal of Pharmaceutical Sciences 143, pages 105173.
Crossref

Vaishali Y. Londhe & Bhavya Bhasin. (2019) Transdermal lipid vesicular delivery of iloperidone: Formulation, in vitro and in vivo evaluation. Colloids and Surfaces B: Biointerfaces 183, pages 110409.
Crossref

Aishwarya K. Rajagopalan, William K. Bache, Serena Z. Chen, Ermal Bojdani & Kevin J. Li. (2019) New-generation Antipsychotics and Cardiovascular Risk. Current Treatment Options in Psychiatry 6:2, pages 154-163.
Crossref

Koen Demyttenaere, Johan Detraux, Giorgio Racagni & Kristof Vansteelandt. (2019) Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis. CNS Drugs 33:6, pages 549-566.
Crossref

Jonathan M. Meyer & Stephen M. Stahl. 2021. The Clozapine Handbook. The Clozapine Handbook 78 89 .

Viswam Subeesh, Eswaran Maheswari, Hemendra Singh, Thomas Elsa Beulah & Ann Mary Swaroop. (2019) Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Current Drug Safety 14:1, pages 21-26.
Crossref

Ch Gangu Naidu, R Nageswara Rao, A V Prasada Rao, K Nagesh Kumar, Raju Padiya & V Madhusudhan Rao. (2018) Supported liquid extraction and LC–MS-MS determination of iloperidone and olanzapine in rat plasma: Application to a pharmacokinetic study. Journal of Chromatographic Science 56:10, pages 879-887.
Crossref

Yong Kee Choi & Frank I. Tarazi. (2018) Long-Term Effects of Iloperidone on Cerebral Serotonin and Adrenoceptor Subtypes. Journal of Molecular Neuroscience 66:1, pages 59-67.
Crossref

Sukanya Pandeti, Tofan Kumar Rout, Narender Tadigoppula & Jagadeshwar Reddy Thota. (2017) Identification of stress degradation products of iloperidone using liquid chromatography coupled with an Orbitrap mass spectrometer. Rapid Communications in Mass Spectrometry 31:16, pages 1324-1332.
Crossref

Vanteemar S. Sreeraj, Venkataram Shivakumar, Naren P. Rao & Ganesan Venkatasubramanian. (2017) A critical appraisal of long acting injectable antipsychotics: Translating research to clinics. Asian Journal of Psychiatry 28, pages 57-64.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy

Articles from other publishers (17)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy

Citations (17)

Articles from other publishers (17)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date